Clinical trial · Observational
Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium
NCT04117386CI-TRIAL-00045949completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prevalence of HPV-associated eye infection and cytokine levels in tears from patients diagnosed with pterygium
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Human Papilloma Virus Infection | — | UNRESOLVED | — |
| Pterygium | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bio-Plex® 200 system (Bio- Rad, Hercules, CA) | Diagnostic Test | — | UNRESOLVED |
| HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Primary pterygium group
- description
- Participants who was diagnosed with primary pterygium
- interventionNames
- Diagnostic Test: HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
- Diagnostic Test: Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
- label
- Secondary pterygium group
- description
- Participants who was diagnosed with secondary pterygium
- interventionNames
- Diagnostic Test: HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
- Diagnostic Test: Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
- label
- Healthy participants as control group
- description
- Participants who have no pterygium and other inflammation disease in eyes
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Participants as primary and secondary pterygium group Inclusion Criteria: * Age above 18 years old * presence of pterygium invading the cornea Exclusion Criteria: * Other ocular inflammation that could affect the results of the study (such as conjunctivitis, keratitis, conjunctival tumor, etc) or would preclude the enrollment for safety reasons Participant without ocular disease Inclusion criteria * Age above 18 years old Exclusion criteria * Presence of any ocular inflammation diseases
References
Publications (0)
Data not yet available
No reference posted for this study.